
Sign up to save your podcasts
Or


Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation.
Research discussed
Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab
Factors Associated with Remission of Eczema in Children
Persistence of Mild to Moderate Atopic Dermatitis
Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children
By Global Parents for Eczema Research (GPER)5
99 ratings
Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation.
Research discussed
Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab
Factors Associated with Remission of Eczema in Children
Persistence of Mild to Moderate Atopic Dermatitis
Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children

112,934 Listeners

43 Listeners

368,699 Listeners

20,212 Listeners

86 Listeners

33 Listeners

3,100 Listeners